Risk-Based Monitoring of Clinical Trials Using JMP Clinical

Risk-Based Monitoring of Clinical Trials Using JMP Clinical

Extensive on-site review of clinical trial data has proven to be time consuming, expensive, limited in scope and prone to error. And unfortunately, some of the expense is passed onto the patient in the cost of the drug.

Risk-based monitoring can alleviate some of these costs and improve the quality of the data through use of a central computerized review of clinical trial data and site metrics. It can also help to determine if sites need more extensive quality review through actual on-site monitoring visits.

This paper demonstrates how a clinical trial team reviewed data remotely to protect the well-being of patients and ensure the integrity of final study results. It also discusses the tools used for identifying potentially fraudulent data at clinical sites.

*
*
*
*
  향후 JMP 사용자를 위한 월간 뉴스레터인 Monthly User Guide를 수신하는 데 동의합니다.
  향후 JMP에서 제공하는 제품 정보 및 서비스를 수신하는 데 동의합니다. 언제든지 JMP에서 이메일을 수신 거부할 수 있습니다.

JMP는 SAS Institute Inc.의 한 부서이며 귀하의 정보는 SAS 개인 정보 보호 정책 준칙에 따라 존중하며 보호합니다.

 
 

Back to Top